Lataa...
DNA-launched live-attenuated vaccines for biodefense applications
A novel vaccine platform uses DNA immunization to launch live-attenuated virus vaccines in vivo. This technology has been applied for vaccine development against positive-strand RNA viruses with global public health impact including alphaviruses and flaviviruses. The DNA-launched vaccine represents...
Tallennettuna:
| Julkaisussa: | Expert Rev Vaccines |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5033646/ https://ncbi.nlm.nih.gov/pubmed/27055100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14760584.2016.1175943 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|